Anavex Life Sciences Corp (AVXL)

[sokol]

Patent filed the latter part of 2016?

It will be interesting to see what the most recent Anavex patent application is about. This is U.S. patent application 15/194792. It has not been published yet, to my knowledge. Perhaps someone more astute than me may elaborate. Orveko commented about this sometime the latter part of last year:

''1) U.S. patent application 15/194792 -

Title and information not yet known (this patent has not been published yet), however this patent application is a child of both 14/395581 and 14/865862, so is likely related to Anavex 19-144 and/or Anavex 2-73.

2) U.S. patent application 14/395581 - "Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands"

Priority date: 03/28/2013
Filing date: 04/03/2013
Publication date: 03/12/2015

3) U.S. patent application 14/865862 - "Prototypical brain protective activity of tetrahydro-n-methyl-2,2-diphenyl-3-furanomethanamine (AE37Met)"

Priority date: 03/28/2013
Filing date: 09/25/2015
Publication: date 01/14/2016 ''